Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 267

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Endothelial Progenitor Cells: New Hope for a Broken Heart

Szmitko, Paul E., Fedak, Paul W.M., Weisel, Richard D., Stewart, Duncan J., Kutryk, Michael J.B., Verma, Subodh · 2003 · Circulation

Abstract

HomeCirculationVol. 107, No. 24Endothelial Progenitor Cells Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBEndothelial Progenitor CellsNew Hope for a Broken Heart Paul E. Szmitko, Paul W.M. Fedak, Richard D. Weisel, Duncan J. Stewart, Michael J.B. Kutryk and Subodh Verma Paul E. SzmitkoPaul E. Szmitko From the Divisions of Cardiology (D.J.S., M.J.B.K.) and Cardiac Surgery (P.E.S., P.W.M.F., R.D.W., S.V.), University of Toronto, Toronto, Ontario, Canada. , Paul W.M. FedakPaul W.M. Fedak From the Divisions of Cardiology (D.J.S., M.J.B.K.) and Cardiac Surgery (P.E.S., P.W.M.F., R.D.W., S.V.), University of Toronto, Toronto, Ontario, Canada. , Richard D. WeiselRichard D. Weisel From the Divisions of Cardiology (D.J.S., M.J.B.K.) and Cardiac Surgery (P.E.S., P.W.M.F., R.D.W., S.V.), University of Toronto, Toronto, Ontario, Canada. , Duncan J. StewartDuncan J. Stewart From the Divisions of Cardiology (D.J.S., M.J.B.K.) and Cardiac Surgery (P.E.S., P.W.M.F., R.D.W., S.V.), University of Toronto, Toronto, Ontario, Canada. , Michael J.B. KutrykMichael J.B. Kutryk From the Divisions of Cardiology (D.J.S., M.J.B.K.) and Cardiac Surgery (P.E.S., P.W.M.F., R.D.W., S.V.), University of Toronto, Toronto, Ontario, Canada. and Subodh VermaSubodh Verma From the Divisions of Cardiology (D.J.S., M.J.B.K.) and Cardiac Surgery (P.E.S., P.W.M.F., R.D.W., S.V.), University of Toronto, Toronto, Ontario, Canada. Originally published24 Jun 2003https://doi.org/10.1161/01.CIR.0000074242.66719.4ACirculation. 2003;107:3093–3100Mr S. is a 62-year-old restaurant owner who has had recurrent stable angina that has not improved despite maximal medical therapy and an earlier coronary bypass. On angiography, Mr S. has diffusely diseased coronary vessels and is no longer considered a candidate for further direct revascularization. An alternative treatment strategy for revascularizing ischemic tissue is therefore required. One potential strategy, therapeutic neovascularization, aims to promote the formation of natural bypasses or collaterals within the ischemic tissue by harvesting the potential of endothelial progenitor cells (EPCs). This From Bench to Bedside article will explore the current concept of an EPC, the role EPCs play in neovascularization, the strategies used to maximize EPC number and function, the experimental and clinical evidence supporting EPC utility, and the future direction of EPC research.See p 2995What Are EPCs?Progenitor cells are primitive bone marrow (BM) cells that have the capacity to proliferate, migrate, and differentiate into various mature cell types. EPCs, in particular, possess the ability to mature into the cells that line the lumen of blood vessels.1 The first evidence indicating the presence of EPCs in the adult circulation emerged when mononuclear blood cells from healthy human volunteers were shown to acquire an endothelial cell–like phenotype in vitro and to incorporate into capillaries in vivo.2 These putative EPCs were characterized via expression of CD34 and vascular endothelial growth factor receptor-2 (VEGFR-2), 2 antigens shared by embryonic endothelial progenitors, and hematopoietic stem cells (HSCs). Subsequent studies confirmed that CD34+ cells isolated from BM or umbilical cord blood also had the capacity to differentiate into mature endothelial cells.3–5 However, both CD34 and VEGFR-2 are expressed on mature endothelial cells.6 Thus, the search for more unique EPC markers continued.In addition to CD34, early hematopoietic progenitor cells express CD133 (AC133), which is not expressed after differentiation.6,7 Using CD133 expression to define a very early subset of progenitor cells, Peichev et al8 isolated a VEGFR-2+/CD133+/CD34+ subpopulation of cells able to differentiate into mature endothelial cells. More recently, hematopoietic progenitor cells that express CD34 and fibroblast growth factor receptor-1, or coexpress CD34, CD133, and VEGFR-3, have been shown to behave as EPCs.9,10Currently, most studies that estimate the number of EPCs in the circulation measure the number of CD34+/VEGFR-2+ or CD133+/VEGFR-2+ cells.11,12 However, the expression of CD34 does not appear to be an absolute requirement for EPC identification. Populations of CD34− HSCs and CD34−/CD133+/VEGFR-2+ mesenchymal stem cells have been demonstrated to give rise to EPCs and generate mature endothelial cells.13,14 Thus, the lineage and exact phenotype of EPCs are not yet known.What Roles Do EPCs Have in the Adult?The endothelium is a single-cell lining covering the internal surface of blood vessels, cardiac valves, and numerous body cavities that plays an important role in thrombogenicity, anticoagulation, leukocyte and platelet adherence, and vessel wall contraction and relaxation.15 Endothelial dysfunction predisposes to vasoconstriction, thrombosis, an

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000074242.66719.4a

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 267

Metadata

Authors
Szmitko, P. E., Fedak, P. W. M., Weisel, R. D., Stewart, D. J., Kutryk, M. J. B., & Verma, S.
Venue
Circulation
Published
2003-06-24
Volume
107
Issue
24
Pages
3093-3100
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2113117342
Cited by
267
References
75
FWCI
11.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endothelial Progenitor Cells: New Hope for a Broken Heart. https://app.cochat.ai/papers/10.1161/01.cir.0000074242.66719.4a
The paper
Szmitko, P. E., Fedak, P. W. M., Weisel, R. D., Stewart, D. J., Kutryk, M. J. B., & Verma, S. (2003). Endothelial Progenitor Cells: New Hope for a Broken Heart. Circulation. https://doi.org/10.1161/01.cir.0000074242.66719.4a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.